We are live on ! Find out more
WCMNY

Westchester Capital Management (New York) Portfolio holdings

AUM $2.21B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+99.86%
5 Year Est. Return
+236.34%
10 Year Est. Return
+1,523.35%
AUM
$3.64B
AUM Growth
+$85.7M
Cap. Flow
-$35.8M
Cap. Flow %
-0.98%
Top 10 Hldgs %
32.26%
Holding
629
New
150
Increased
117
Reduced
17
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 41.42%
2 Technology 12.77%
3 Healthcare 11.09%
4 Industrials 10.67%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FHN icon
1
First Horizon
FHN
$12.1B
$159M 4.37%
6,489,724
+642,983
+11% +$15.6M
HZNP
2
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$143M 3.92%
+1,253,044
New +$104M
VMW
3
DELISTED
VMware, Inc
VMW
$136M 3.73%
1,107,370
+241,004
+28% +$27.8M
STOR
4
DELISTED
STORE Capital Corporation
STOR
$127M 3.48%
3,952,180
+842,175
+27% +$26.7M
LHCG
5
DELISTED
LHC Group LLC
LHCG
$125M 3.45%
776,102
+155,363
+25% +$25.7M
AAWW
6
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$111M 3.05%
1,099,581
+21,202
+2% +$2.12M
SPY icon
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$105M 2.89%
275,000
-25,000
-8% -$9.61M
ONEM
8
DELISTED
1Life Healthcare
ONEM
$104M 2.87%
6,240,757
+670,664
+12% +$11.3M
ATVI
9
DELISTED
Activision Blizzard
ATVI
$86.9M 2.39%
1,134,871
+386,200
+52% +$28.7M
SJR
10
DELISTED
Shaw Communications Inc.
SJR
$77.4M 2.13%
2,690,570
+1,842,659
+217% +$48.3M
SGFY
11
DELISTED
Signify Health, Inc.
SGFY
$63.6M 1.75%
2,220,552
+1,720,026
+344% +$49.6M
ATCO
12
DELISTED
Atlas Corp.
ATCO
$50.4M 1.38%
3,285,904
+3,164,847
+2,614% +$47.8M
EVOP
13
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$49.9M 1.37%
1,473,505
-54,166
-4% -$1.82M
AUY
14
DELISTED
Yamana Gold, Inc.
AUY
$47.4M 1.3%
+8,549,285
New +$43.2M
SWIR
15
DELISTED
Sierra Wireless
SWIR
$42.7M 1.17%
1,471,673
+1,457,914
+10,596% +$42.9M
JWSM
16
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$39.4M 1.08%
3,902,109
+2,645,089
+210% +$26.5M
AAC
17
DELISTED
Ares Acquisition Corporation
AAC
$34.1M 0.94%
3,386,790
+2,473,449
+271% +$24.7M
CMBT
18
CMB.TECH NV
CMBT
$4.73B
$29.5M 0.81%
1,730,449
+1,531,725
+771% +$27.6M
MGI
19
DELISTED
MoneyGram International, Inc. New
MGI
$27.8M 0.76%
2,549,663
APGB
20
DELISTED
Apollo Strategic Growth Capital II
APGB
$26.8M 0.73%
2,669,685
+1,909,996
+251% +$19M
TGNA
21
DELISTED
TEGNA Inc
TGNA
$26.6M 0.73%
1,257,606
-1,107,555
-47% -$22.3M
COUP
22
DELISTED
Coupa Software Incorporated
COUP
$26.3M 0.72%
+331,749
New +$19.8M
AIMC
23
DELISTED
Altra Industrial Motion Corp
AIMC
$25.6M 0.7%
+427,868
New +$22.5M
CVII
24
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$23.1M 0.64%
2,319,831
+1,282,737
+124% +$12.7M
FPAC
25
DELISTED
Far Peak Acquisition Corporation
FPAC
$22M 0.6%
2,188,229
+1,498,679
+217% +$14.9M

Similar funds

Westchester Capital Management (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Westchester Capital Management (New York) held 629 positions worth $3.64B, up 2.4% from $3.55B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Westchester Capital Management (New York)'s Q4 2022 filing shows 150 new, 117 increased, 17 reduced and 182 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $143M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

  • Westchester Capital Management (New York)'s largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M.
  • Westchester Capital Management (New York) added most to Signify Health, Inc. in Q4 2022, an estimated $49.6M increase.
  • Westchester Capital Management (New York)'s biggest Q4 2022 reduction was Silicon Motion, cutting an estimated $61.4M.
  • Westchester Capital Management (New York) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $143M.
  • Westchester Capital Management (New York)'s ten largest holdings make up 32% of its $3.64B portfolio in Q4 2022.
  • Westchester Capital Management (New York) opened 150 new positions and closed 182 in Q4 2022.
  • Westchester Capital Management (New York)'s portfolio value rose 2.4% quarter-over-quarter to $3.64B.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.